BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7530598)

  • 21. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
    Nilsson H; Björk P; Dohlsten M; Antonsson P
    J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.
    Holzer U; Orlikowsky T; Zehrer C; Bethge W; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Immunology; 1997 Jan; 90(1):74-80. PubMed ID: 9038715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superantigen-induced lysis of melanoma cells.
    Krull F; Holzer U; Ihle J; Bethge W; Fierlbeck G; Kalland T; Dohlsten M; Niethammer D; Dannecker GE
    Melanoma Res; 1997 Jun; 7(3):214-22. PubMed ID: 9195560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
    Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
    Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HLA class I antibody inhibits Staphylococcus enterotoxin A (SEA)-induced proliferation of human PBMC.
    Baskar P; Hildreth JE; Chrest FJ; Nagel JE; Adler WH
    Cell Immunol; 1996 Aug; 172(1):135-8. PubMed ID: 8806816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
    Kuge S; Miura Y; Nakamura Y; Mitomi T; Habu S; Nishimura T
    J Immunol; 1995 Feb; 154(4):1777-85. PubMed ID: 7836762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
    Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
    Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
    Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and in-vitro bioactivity of a novel superantigen conjugate targeting bladder carcinoma.
    Zhen G; Cong-hui H; Lin H; Jian-jun Y; Wen-hao T; Gao-jun T
    J Pharm Pharmacol; 2009 Jul; 61(7):869-75. PubMed ID: 19589228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.
    Rosendahl A; Kristensson K; Hansson J; Riesbeck K; Kalland T; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5309-13. PubMed ID: 9605129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the binding of staphylococcal enterotoxin D to the T cell receptor Vbeta chain and major histocompatibility complex class II.
    Li Y; Zhu X; Huang Y; Xiong H
    Immunol Lett; 2006 May; 105(1):55-60. PubMed ID: 16481046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of T cells by superantigen in class II-negative mice.
    Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
    J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of staphylococcal enterotoxin A to purified murine MHC class II molecules in supported lipid bilayers.
    Lee JM; Watts TH
    J Immunol; 1990 Nov; 145(10):3360-6. PubMed ID: 2230121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
    Lamphear JG; Bohach GA; Rich RR
    J Immunol; 1998 Mar; 160(5):2107-14. PubMed ID: 9498747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR.
    Antonsson P; Wingren AG; Hansson J; Kalland T; Varga M; Dohlsten M
    J Immunol; 1997 May; 158(9):4245-51. PubMed ID: 9126986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.